In The Press
Ovation Science Inc. Closes $2,415,000 IPO and is Listed
Vancouver, BC – November 15, 2018 (CSE: OVAT) – Ovation Science Inc. (“Ovation” or the “Company”) announces that it has closed its Initial Public Offering of units at $0.30 per unit (the “Units”) pursuant to its final prospectus dated October 26, 2018 (the “Prospectus”).
Ovation Signs Exclusive License Agreement to Distribute Its Topical Cannabis Products in the USA
Skinvisible Pharmaceuticals, Inc. ("Skinvisible"), a research and development company with a patented drug delivery system called Invisicare®, today announces the formation of its Ovation Science, Inc. subsidiary, and the company's definitive license agreement with Lighthouse Strategies...
Canopy Growth and Ovation Sign Definitive Agreement to Bring New Products to Market
Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX: WEED) and Skinvisible Pharmaceuticals, Inc. ("Skinvisible"), a research and development company with a patented drug delivery system, today announce they have signed a definitive license agreement for...